GENMAB A/S -SP ADR
GMABNASDAQEarnings Nov 5US Equity
$30.85▼ $0.02 (−0.06%)
Market closed · at close1h—
24h▼ 0.1%
7d▲ 5.4%
14d▲ 8.2%
30d▲ 7.1%
1y▲ 41.0%
🏦Market Cap
$1.92B
Small Cap
📈Revenue Growth (YoY)
+20.7%
Healthy
📊Gross Margin
93.3%
High
💵FCF Margin
29.0%
Strong
⚖️P/S Ratio
4.7x
Fair
Otter Score
56
Weak
Earnings
Q3 · 2026Reported 2026-08-06Earnings Per Share
Actual
0.54
Expected
0.37
beat
+45.90%
YoY +0.00%
Revenue
Actual
$1.16B
Expected
$1.12B
beat
+3.50%
YoY +24.90%
Consensus estimates
Recent quarters
Q3 2026
0.54
beat
Q2 2026
0.09
miss
Q1 2026
0.05
miss
Q4 2025
0.65
beat